Skip to main content
SpringerLink
Log in

Effect of intravenous atropine and methylatropine on heart rate and secretion of saliva in man

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Intravenous atropine sulphate (0.25, 0.40, 0.75 and 1.50 mg), atropine methylnitrate (0.08, 0.13 and 0.25 mg) and saline were given to 72 healthy medical students. The effects on heart rate and rhythm, systolic and diastolic blood pressure and salivary secretion were studied. Salivation was inhibited by all the doses of the two drugs. There was a clear dose-response relationship and methylatropine was about 3 times as potent as atropine. Heart rate was accelerated by 0.75 and 1.50 mg atropine, and 0.25 mg methylatropine, whereas 0.25 mg atropine and 0.08 and 0.13 mg methylatropine induced bradycardia, which was considered to be due to a peripheral action. It is suggested that the drugs act as partial agonists at muscarinic receptors. No clear effect on blood pressure was seen, except for the highest dose of atropine, after which the diastolic pressure was increased. 20 out of 59 subjects who received anticholinergics developed supra-ventricular arrhythmias; with both drugs periods of nodal rhythm were most common. They appeared shortly after the injection and usually lasted for a few minutes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Akhter, M.H., Bhide, N.K.: Acetylcholine-like action of atropine on the ciliary epithelium of the frog oesophagus during the warmer months. J. Pharm. Pharmacol.23 815–816 (1971)

    Google Scholar 

  • Albanus, L.: Central and peripheral effects of anticholinergic compounds. Acta Pharmacol. (Kbh.)28 305–326 (1970)

    Google Scholar 

  • Ashford, A., Penn, G.B., Ross, J.W.: Cholinergic activity of atropine. Nature (Lond.)193 1082–1083 (1962)

    Google Scholar 

  • Averill, K.H., Lamb, L.E.: Less commonly recognized actions of atropine on cardiac rhythm. Amer. J. med. Sci.237 304–318 (1959)

    Google Scholar 

  • Bagshaw, H., Chamberlain, D.A., Turner, P.: Comparison of atropine and (−)-hyoscyamine on heart rate in man. Brit. J. Pharmacol.40 600–601 (1970)

    Google Scholar 

  • Bauer, R., Gross, E., Scarselli, V., Stockhaus, K., Wick, H.: Über Wirkungsunterschiede von Atropin, Scopolamin und einigen ihrer quartären Derivate nach subcutaner und enteraler Gabe unter besonderer Berücksichtigung des Scopolamin-n-butyl-bromids. Arzneimittel-Forsch.18 1132–1137 (1968)

    Google Scholar 

  • Brown, A.M.: Cardiac sympathetic adrenergic pathways in which synaptic transmission is blocked by atropine sulphate. J. Physiol. (Lond.)191 271–288 (1967)

    Google Scholar 

  • Burn, J.H.: Functions of autonomic transmitters. Baltimore: Williams & Wilkins Company 1956

    Google Scholar 

  • Chamberlain, D.A., Turner, P., Sneddon, J.M.: Effects of atropine on heart-rate in healthy man. Lancet 1967/II, 12–15

    Google Scholar 

  • Craig, F.N.: Inhibition of sweating by salts of hyoscine and hyoscyamine. J. appl. Physiol.28 779–783 (1970)

    Google Scholar 

  • Cullumbine, H., McKee, W.H.E., Creasey, N.H.: The effects of atropine sulphate upon healthy male subjects. Quart. J. exp. Physiol.40 309–319 (1955)

    Google Scholar 

  • Dauchot, P., Gravenstein, J.S.: Effects of atropine on the electrocardiogram in different age groups. Clin. Pharmacol. Ther.12 274–280 (1970)

    Google Scholar 

  • Eger, E.I.: Atropine, scopolamine, and related compounds. Anesthesiology23 365–383 (1962)

    Google Scholar 

  • Gaskell, P.: The effect of intra-arterial atropine infusions on the blood flow through the human hand and forearm. J. Physiol. (Lond.)131 639–646 (1956)

    Google Scholar 

  • Goodman, L.S., Gilman, G.: The pharmacological basis of therapeutics. New York: MacMillan Company 1970

    Google Scholar 

  • Gorten, R., Gunnells, J.C., Weissler, A.M., Stead, E.A.: Effects of atropine and isoproterenol on cardiac output, central venous pressure, and mean transit time of indicators placed at three different sites in the venous system. Circulat. Res.9 979–983 (1961)

    Google Scholar 

  • Gravenstein, J.S., Andersen, T.W., De Padua, C.B.: Effects of atropine and scopolamine on the cardiovascular system in man. Anesthesiology25 123–130 (1964)

    Google Scholar 

  • Gravenstein, J.S., Ariet, M., Thornby, J.I.: Atropine on the electrocardiogram. Clin. Pharmacol. Ther.10 660–666 (1969)

    Google Scholar 

  • Hardegg, W., Rieken, E., Schmaltz, H.: Über die Beeinflussung der menschlichen Blut-Cholinesterasen durch Atropin. Pflügers Arch. ges. Physiol.259 317–333 (1954)

    Google Scholar 

  • Harris, I.: The action of digitalis and atropine on the peripheral blood pressure. Lancet 1921,99 1072–1074

    Google Scholar 

  • Hayes, A.H., Parr, G.V.S.: Comparison of the actions of homatropine hydrobromide and homatropine methylbromide on human heart rate. Fed. Proc.29:2 2791 (1970)

    Google Scholar 

  • Hayes, A.H., Copelan, H.W., Ketchum, J.S.: Effects of large intramuscular doses of atropine on cardiac rhythm. Clin. Pharmacol. Ther.12 482–486 (1971)

    Google Scholar 

  • Hazard, R., Savini, E., Renier-Cornec, A.: Augmentation par des doses minimes d'atropine de la sensibilité de l'intestin isolé à l'acétylcholine. Arch. Int. Pharmacodyn. Ther.120 369–373 (1959)

    Google Scholar 

  • Heinekamp, W.J.E.: The central influence of atropine and hyoscine on the heart rate. J. Lab. clin. Med.8 104–111 (1922)

    Google Scholar 

  • Herxheimer, A., Haefeli, L.: Human pharmacology of hyoscine butylbromide. Lancet1966 II 418–421

    Google Scholar 

  • Herz, A., Teschemacher, H., Hofstetter, A., Kurz, H.: The importance of lipid-solubility for the central action of cholinolytic drugs. Int. J. Neuropharmacol.4 207–218 (1965)

    Google Scholar 

  • Issekutz, B. v.: Über die Wirkung der Tropeine und ihrer quaternären Ammoniumbasen. Z. exp. Pathol. Ther.19 99–117 (1913)

    Google Scholar 

  • Jones, R.E., Deutsch, S., Turndorf, H.: Effects of atropine on cardiac rhythm in conscious and anesthetized man. Anesthesiology22 67–73 (1961)

    Google Scholar 

  • Khavari, K.A., Maickel, R.P.: Atropine and atropine methylbromide effects on behavior of rats. Int. J. Neuropharmacol.6 301–306 (1967)

    Google Scholar 

  • Kottmeier, C.A., Gravenstein, J.S.: The parasympathomimetic activity of atropine and atropine methylbromide. Anesthesiology29 1125–1133 (1968)

    Google Scholar 

  • Lindström, L., Meyerson, B.: The effect of pilocarpine, oxotremorine and arecoline in combination with methyl-atropine or atropine on hormone activated oestrous behaviour in ovariectomized rats. Psychopharmacologia (Berl.)11 405–413 (1967)

    Google Scholar 

  • Lüllmann, H., Förster, W., Westermann, E.: Über eine “paradoxe” Atropinwirkung an isolierten Organen und ihre statistische Erfassung. Arch. exp. Pathol. Pharmakol.215 8–18 (1952)

    Google Scholar 

  • McGuigan, H.: The effect of small doses of atropine on the heart rate. J. Amer. med. Ass.76 1338–1340 (1921)

    Google Scholar 

  • Morton, H.J.V., Thomas, E.T.: Effect of atropine on the heart rate. Lancet 1958/II, 1313–1315

    Google Scholar 

  • Nalefski, L.A., Brown, C.F.G.: Action of atropine on the cardiovascular system in normal persons. Arch. intern. Med.86 898–907 (1950)

    Google Scholar 

  • Nishi, K., Eyzaguirre, C.: The action of some cholinergic blockers on carotid body chemoreceptorsin vivo. Brain Res.33 37–56 (1971)

    Google Scholar 

  • de Padua, C.B., Gravenstein, J.S.: Atropine sulphate vs atropine methylbromide. J.Amer. med. Ass.208 1022–1023 (1969)

    Google Scholar 

  • Paintal, A.S.: Effects of drugs on vertebrate mechanoreceptors. Pharmacol. Rev.16 341–380 (1964)

    Google Scholar 

  • Paintal, A.S.: Action of drugs on sensory nerve endings. Ann. Rev. Pharmacol.11 231–240 (1971)

    Google Scholar 

  • Pohto, P., Ahtee, L.: Effect of atropine, methylatropine, methylscopolamine and pilocarpine on salivary secretion and heart rate in man. Ann. Med. exp. Fenn.44 411–414 (1966)

    Google Scholar 

  • Rudolf, R.D., Bulmer, F.M.R.: Some cardiac effects of atropine. Amer. J. med. Sci.168 641–647 (1924)

    Google Scholar 

  • Sollman, T.: A manual of pharmacology, 8th ed., Philadelphia: W.B. Saunders Company 1957

    Google Scholar 

  • Sundvall, A., Vessman, J., Strindberg, B.: Fate of emepronium in man in relation to its pharmacological effects. Europ. J. clin. Pharmacol.,6 191–195 (1973)

    Google Scholar 

  • Szerb, J.C.: The effect of tertiary and quaternary atropine on cortical acetylcholine output and on the electroencephalogram in cats. Canad. J. Physiol. Pharmacol.42 303–314 (1964)

    Google Scholar 

  • Teitel, A.: Cholinergic activity of hyoscyamine. Nature (Lond.)190 814–815 (1961)

    Google Scholar 

  • Turner, P.: Clinical aspects of autonomic pharmacology. London: W. Heinemann Medical Books Ltd. 1969

    Google Scholar 

  • Wahlström, G., Widerlöv, E.: Jämförelse mellan intramuskulärt och peroralt effektiva doser av metylskopolamin. Läkartidningen65 86–94 (1968)

    Google Scholar 

  • Wilson, F.N.: The production of atrioventricular rhythm in man after the administration of atropin. Arch. intern. Med.16 989–1007 (1915)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Pharmacology, University of Uppsala, Uppsala, Sweden

    G. Lönnerholm & E. Widerlöv

Authors
  1. G. Lönnerholm
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Widerlöv
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lönnerholm, G., Widerlöv, E. Effect of intravenous atropine and methylatropine on heart rate and secretion of saliva in man. Eur J Clin Pharmacol 8, 233–240 (1975). https://doi.org/10.1007/BF00567121

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00567121

Key words

Search

Navigation